One-year Functional Outcomes after Holmium Laser Enucleation of the Prostate (HoLEP): Introduction of a Composite Score (Hexafecta)
| Autor: | Lionel Badet, Hakim Fassi-Fehri, Sebastien Crouzet, X. Matillon, C. Michaud, R. Codas-Duarte |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Complete data Composite score Urology media_common.quotation_subject Enucleation Holmium laser Prostatic Hyperplasia Lasers Solid-State Urination Holmium Quality of life Prostate medicine Humans media_common Retrospective Studies business.industry Transurethral Resection of Prostate Retrospective cohort study medicine.anatomical_structure Treatment Outcome Quality of Life Laser Therapy business |
| Zdroj: | Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 32(3) |
| ISSN: | 1166-7087 |
| Popis: | OBJECTIVE To compare the efficiency (micturition symptoms, continence, erection) and safety of Holmium Laser Enucleation of the Prostate (HoLEP) with a single composite score (the Hexafecta score) one year postprocedure. PATIENTS AND METHODS We conducted a single-center retrospective study including all patients who had undergone HoLEP for the treatment of benign prostate hyperplasia (BPH) between May 2013 and August 2017. Data were obtained preoperatively and at the 6- and 12-month visits. We also reported all 90-day complications. The Hexafecta score included 6 criteria: peak urine flow of at least 15ml/s, 30% reduction in International Prostate Symptoms Score (IPSS) score, quality of life via the IPSS less than 2, no incontinence (International Consultation Incontinence Questionnaire), no significant change in erectile function (International Index of Erectile Function), and no grade III or more complications according to the Clavien-Dindo classification. RESULTS Two hundred thirty-five patients were included, of whom 197 (83.8%) completed the 12-month visit. Complete data were available to assess the Hexafecta score for 178 of them (75.7%). Most of the missing data were for uroflowmetry and the erectile function assessment. Hundred three patients (58%) met all 6 criteria, while 45 (25%) met 5 of them. None were retreated for BPH in the follow-up period. The de novo incontinence rate was 4.1%. CONCLUSION The Hexafecta score is a simple, transversal method for comprehensively evaluating functional outcomes after HoLEP surgery. Such an evaluation could be used to compare other types of procedures for BPH treatment. LEVEL OF EVIDENCE 3. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|